CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

VIONA PHARMACEUTICALS INC recalls Dapsone Gel 7.5%

Read the official FDA notice

Published
8 Jan 2025
Units affected
2 products
Agency
FDA
Country
United States

The hazard

Crystallization

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Dapsone Gel 7.5%, 90 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-03. packaged in an Airless pump pack

Dapsone Gel 7.5%, 60 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahemedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02. packaged in an Airless pump pack

Brand / company
VIONA PHARMACEUTICALS INC
Codes / lots
Lots T400514, Exp Date 02/2026 & T400808, Exp Date 03/2026 | Lots T400513, Exp Date 02/2026; T400807, Exp Date 03/2026; T401152, Exp Date 06/2026; T401303, Exp Date 07/2026; T401304, Exp Date 07/2026; T401399, Exp Date 07/2026 & T401696 Exp Date 08/2026.
Distribution
US Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 8 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.